It seems pretty clear that extremities are the next big growth opportunity in orthopedics. Of course, "big" is a relative statement - the market for implants and tools to repair shoulders, elbows, ankles, and feet is only about 10% the size of the market for spine care, and only about 25% of the size of the spinal fusion market. Even so, double-digit market growth tends to attract attention, and that could be a good thing for Tornier (TRNX) - an extremities-focused small cap with strong share in this emerging market.
Right now, Tornier is still a company in transition. Not only did the company see a rather sudden CEO/CFO change a year ago, but Tornier is also...
Only subscribers can access this article, which is part of the PRO research library covering 3,580 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: